Streetbeat News

Analyst Ratings

SKIN

The Beauty Health Company's stock (SKIN) is trading lower following a downgrade by Jefferies from Buy to Hold and a significant reduction in the price target from $11 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:39 pm

CAE

RBC Capital analyst Walter Spracklin has maintained an Outperform rating on CAE but has lowered the price target from C$37 to C$34.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:35 pm

ACLX

Needham analyst Gil Blum has reaffirmed a Buy rating on Arcellx (NASDAQ:ACLX) and increased the price target from $51 to $60, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:35 pm

VREX

Oppenheimer analyst Suraj Kalia has maintained an Outperform rating on Varex Imaging (NASDAQ:VREX) but has reduced the price target from $42 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:28 pm

URGN

Oppenheimer analyst Leland Gershell has maintained an Outperform rating on UroGen Pharma (NASDAQ:URGN) but has reduced the price target from $33 to $32.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:23 pm

AEO

Citigroup analyst Paul Lejuez has maintained a Neutral rating on American Eagle Outfitters (NYSE:AEO) and increased the price target from $18 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:23 pm

QUIK

Oppenheimer analyst Martin Yang has maintained an Outperform rating on QuickLogic (NASDAQ:QUIK) and increased the price target from $10 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:22 pm